Ayşe Kutluhan Doğan
Research Subjects
Research Interests
Ayşe Kutluhan Doğan has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Nazmiye Deniz Arslan
İSTANBUL YEDİKULE GÖĞÜS HASTALIKLARI VE GÖĞÜS CERRAHİSİ SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ
3 shared publications - Burçak Yılmaz
Nuclear Medicine Department, Biruni University Hospital
2 shared publications - Sedef Dağ2 shared publications
- Colin Brock
School of Biology and Environmental Sciences, University College Dublin, Ireland
1 shared publication - Durval Campos Costaa
Champalimaud Clinical Centre, Champalimaud Foundation , 1400-038 Lisbon
1 shared publication - Emel Canaz
Department of Gynecology with Center for Oncological Surgery, European Comprehensive Center for Ovarian Cancer, Charité Medical University of Berlin, 10117 Berlin, Germany
1 shared publication
Latest Publications
- 1 April 2021
- Published by Galenos Yayinevi in CAM and Sakura Medical Journal
- Vol. 1 (1) , 37-42
Regression of Hypermetabolic Splenic Granulomata Mimicking Metastases Following Non-targeted Effect of Radiotherapy for Uterine Cervical Carcinoma
- 1 April 2021
- Published by Galenos Yayinevi in CAM and Sakura Medical Journal
- Vol. 1 (1) , 37-42
Regression of Hypermetabolic Splenic Granulomata Mimicking Metastases Following Non-targeted Effect of Radiotherapy for Uterine Cervical Carcinoma
- Open Access
- 30 November 2020
- Published by Iskender AKKURT in International Journal of Computational and Experimental Science and Engineering
- Vol. 6 (3) , 145-151
Factors Affecting “Organs at Risk” Doses in 3 Dimensional Brachytherapy (3D BRT) of Cervical and Endometrium Cancers
In brachytherapy, both the tumor and organ at risk may have intrafractional and interfractional anatomical differences. In this study, we aimed to investigate the factors affecting Organs at Risk (OAR) doses in adaptive 3D BRT applications. A total of 55 patients that underwent intracavitary brachytherapy with the diagnosis of a gynecological tumor between September 2012 and December 2013 were evaluated retrospectively. The effect of the surgery, applicator type, bladder, rectum and sigmoid on D2cc, D1cc, D0.1cc values were investigated. The median age was 55 years. While there was no statistically significant difference between 1st and 2nd fractions measurements, the sigmoid D1cc values between the 1st and 3rd fractions were found to be statistically significant (p = 0.004). When the effect of the interfractional change of bladder filling on OAR doses in the first three fractions was examined, it was not statistically significant however, its effect on bladder, sigmoid and rectum D2cc, D1cc, D0.1cc values were observed in some fractions. The bladder point dose was found to be statistically significant in operated patients (p= 0.005). When the comparison was made according to the application type, the bladder dose was found to be statistically significant in roller applications than the other two applicator treatments (p= 0.001). 3D BRT provides maximum protection of healthy tissues while giving a high dose to the target as a result of adaptive planning by performing computed tomography in each fraction. The sigmoid is the OAR that makes the most distinctive interfraction. To obtain higher treatment accuracy in each fraction, routine preparation and tomographic imaging followed by adaptive planning should be done.
- 30 November 2020
- Published by Iskender AKKURT in International Journal of Computational and Experimental Science and Engineering
- Vol. 6 (3) , 145-151
Open AccessFactors Affecting “Organs at Risk” Doses in 3 Dimensional Brachytherapy (3D BRT) of Cervical and Endometrium Cancers
In brachytherapy, both the tumor and organ at risk may have intrafractional and interfractional anatomical differences. In this study, we aimed to investigate the factors affecting Organs at Risk (OAR) doses in adaptive 3D BRT applications. A total of 55 patients that underwent intracavitary brachytherapy with the diagnosis of a gynecological tumor between September 2012 and December 2013 were evaluated retrospectively. The effect of the surgery, applicator type, bladder, rectum and sigmoid on D2cc, D1cc, D0.1cc values were investigated. The median age was 55 years. While there was no statistically significant difference between 1st and 2nd fractions measurements, the sigmoid D1cc values between the 1st and 3rd fractions were found to be statistically significant (p = 0.004). When the effect of the interfractional change of bladder filling on OAR doses in the first three fractions was examined, it was not statistically significant however, its effect on bladder, sigmoid and rectum D2cc, D1cc, D0.1cc values were observed in some fractions. The bladder point dose was found to be statistically significant in operated patients (p= 0.005). When the comparison was made according to the application type, the bladder dose was found to be statistically significant in roller applications than the other two applicator treatments (p= 0.001). 3D BRT provides maximum protection of healthy tissues while giving a high dose to the target as a result of adaptive planning by performing computed tomography in each fraction. The sigmoid is the OAR that makes the most distinctive interfraction. To obtain higher treatment accuracy in each fraction, routine preparation and tomographic imaging followed by adaptive planning should be done.
- 1 August 2002
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 20 (15) , 3347-3349
Challenging Cases and Diagnostic Dilemmas
- 1 August 2002
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 20 (15) , 3347-3349
Challenging Cases and Diagnostic Dilemmas